What is Shanghai Shenqi Pharmaceutical Investment Management Co Operating Cash Flow per Share?
Shanghai Shenqi Pharmaceutical Investment Management Co's operating cash flow per share for the
three
months ended in Mar. 2024 was ¥0.07.
Shanghai Shenqi Pharmaceutical Investment Management Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.45.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Shanghai Shenqi Pharmaceutical Investment Management Co was -11.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 30.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
SHSE:600613'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -81.7 Med: 27.1 Max: 524.9
Current: 30.8
During the past 13 years, Shanghai Shenqi Pharmaceutical Investment Management Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 524.90% per year. The lowest was -81.70% per year. And the median was 27.10% per year.
SHSE:600613's 3-Year OCF Growth Rate is ranked better than 80.12% of 805
companies
in the Drug Manufacturers industry
Industry Median: 7.6
vs SHSE:600613: 30.80
Shanghai Shenqi Pharmaceutical Investment Management Co Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Shenqi Pharmaceutical Investment Management Co Operating Cash Flow per Share Chart
Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Competitive Comparison of Shanghai Shenqi Pharmaceutical Investment Management Co's Operating Cash Flow per Share
For the Drug Manufacturers - General subindustry, Shanghai Shenqi Pharmaceutical Investment Management Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shenqi Pharmaceutical Investment Management Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shenqi Pharmaceutical Investment Management Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Shanghai Shenqi Pharmaceutical Investment Management Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600613 has been successfully added to your 